nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—PTPRS—Extracellular matrix organization—EFEMP1—pancreatic cancer	0.00977	0.0999	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—PRSS1—pancreatic cancer	0.00819	0.0837	CbGpPWpGaD
Etidronic acid—Risedronate—PTGS2—pancreatic cancer	0.00663	0.529	CrCbGaD
Etidronic acid—Clodronate—PTGS2—pancreatic cancer	0.00591	0.471	CrCbGaD
Etidronic acid—Amnesia—Fluorouracil—pancreatic cancer	0.00476	0.00535	CcSEcCtD
Etidronic acid—Osteoarthritis—Irinotecan—pancreatic cancer	0.00467	0.00525	CcSEcCtD
Etidronic acid—Pancytopenia—Sunitinib—pancreatic cancer	0.00465	0.00523	CcSEcCtD
Etidronic acid—Bone pain—Docetaxel—pancreatic cancer	0.00464	0.00522	CcSEcCtD
Etidronic acid—Osteoarthritis—Fluorouracil—pancreatic cancer	0.00447	0.00503	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00433	0.00487	CcSEcCtD
Etidronic acid—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00433	0.00487	CcSEcCtD
Etidronic acid—Erythema multiforme—Erlotinib—pancreatic cancer	0.00428	0.00481	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.00428	0.00481	CcSEcCtD
Etidronic acid—Oesophagitis—Docetaxel—pancreatic cancer	0.00406	0.00457	CcSEcCtD
Etidronic acid—Alopecia—Tamoxifen—pancreatic cancer	0.00405	0.00455	CcSEcCtD
Etidronic acid—Alopecia—Erlotinib—pancreatic cancer	0.004	0.0045	CcSEcCtD
Etidronic acid—Erythema—Tamoxifen—pancreatic cancer	0.00399	0.00448	CcSEcCtD
Etidronic acid—PTPRS—ECM proteoglycans—TGFB1—pancreatic cancer	0.00396	0.0405	CbGpPWpGaD
Etidronic acid—Erythema—Erlotinib—pancreatic cancer	0.00394	0.00443	CcSEcCtD
Etidronic acid—Flatulence—Erlotinib—pancreatic cancer	0.00389	0.00437	CcSEcCtD
Etidronic acid—Muscle spasms—Tamoxifen—pancreatic cancer	0.00383	0.00431	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00381	0.0389	CbGpPWpGaD
Etidronic acid—Pancytopenia—Gemcitabine—pancreatic cancer	0.00373	0.0042	CcSEcCtD
Etidronic acid—Erythema multiforme—Sunitinib—pancreatic cancer	0.00371	0.00417	CcSEcCtD
Etidronic acid—Anaemia—Tamoxifen—pancreatic cancer	0.00368	0.00414	CcSEcCtD
Etidronic acid—Pancytopenia—Fluorouracil—pancreatic cancer	0.00367	0.00413	CcSEcCtD
Etidronic acid—Angioedema—Tamoxifen—pancreatic cancer	0.00364	0.00409	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—CD44—pancreatic cancer	0.00362	0.037	CbGpPWpGaD
Etidronic acid—Leukopenia—Tamoxifen—pancreatic cancer	0.00357	0.00401	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00348	0.00391	CcSEcCtD
Etidronic acid—Alopecia—Sunitinib—pancreatic cancer	0.00347	0.0039	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00344	0.00386	CcSEcCtD
Etidronic acid—Erythema—Sunitinib—pancreatic cancer	0.00341	0.00384	CcSEcCtD
Etidronic acid—Arthralgia—Tamoxifen—pancreatic cancer	0.00339	0.00381	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00338	0.0038	CcSEcCtD
Etidronic acid—Flatulence—Sunitinib—pancreatic cancer	0.00336	0.00378	CcSEcCtD
Etidronic acid—Arthralgia—Erlotinib—pancreatic cancer	0.00336	0.00377	CcSEcCtD
Etidronic acid—Discomfort—Tamoxifen—pancreatic cancer	0.00335	0.00377	CcSEcCtD
Etidronic acid—Arthropathy—Epirubicin—pancreatic cancer	0.0033	0.00371	CcSEcCtD
Etidronic acid—Muscle spasms—Sunitinib—pancreatic cancer	0.00328	0.00369	CcSEcCtD
Etidronic acid—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00327	0.00368	CcSEcCtD
Etidronic acid—Glossitis—Epirubicin—pancreatic cancer	0.00325	0.00366	CcSEcCtD
Etidronic acid—Infection—Tamoxifen—pancreatic cancer	0.00323	0.00363	CcSEcCtD
Etidronic acid—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00322	0.00362	CcSEcCtD
Etidronic acid—Infection—Erlotinib—pancreatic cancer	0.0032	0.00359	CcSEcCtD
Etidronic acid—Anaemia—Sunitinib—pancreatic cancer	0.00316	0.00355	CcSEcCtD
Etidronic acid—Bone pain—Epirubicin—pancreatic cancer	0.00313	0.00352	CcSEcCtD
Etidronic acid—Angioedema—Sunitinib—pancreatic cancer	0.00312	0.00351	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0031	0.0317	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—STK11—pancreatic cancer	0.00307	0.0314	CbGpPWpGaD
Etidronic acid—Leukopenia—Sunitinib—pancreatic cancer	0.00306	0.00344	CcSEcCtD
Etidronic acid—Arthropathy—Doxorubicin—pancreatic cancer	0.00305	0.00343	CcSEcCtD
Etidronic acid—Glossitis—Doxorubicin—pancreatic cancer	0.00301	0.00339	CcSEcCtD
Etidronic acid—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00298	0.00334	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00296	0.00333	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00293	0.0033	CcSEcCtD
Etidronic acid—Paraesthesia—Tamoxifen—pancreatic cancer	0.00292	0.00328	CcSEcCtD
Etidronic acid—Arthralgia—Sunitinib—pancreatic cancer	0.00291	0.00327	CcSEcCtD
Etidronic acid—Bone pain—Doxorubicin—pancreatic cancer	0.0029	0.00326	CcSEcCtD
Etidronic acid—Dyspepsia—Tamoxifen—pancreatic cancer	0.00286	0.00322	CcSEcCtD
Etidronic acid—Alopecia—Irinotecan—pancreatic cancer	0.00285	0.00321	CcSEcCtD
Etidronic acid—Dyspepsia—Erlotinib—pancreatic cancer	0.00283	0.00318	CcSEcCtD
Etidronic acid—Constipation—Tamoxifen—pancreatic cancer	0.00278	0.00313	CcSEcCtD
Etidronic acid—Alopecia—Gemcitabine—pancreatic cancer	0.00278	0.00313	CcSEcCtD
Etidronic acid—Flatulence—Irinotecan—pancreatic cancer	0.00277	0.00311	CcSEcCtD
Etidronic acid—Infection—Sunitinib—pancreatic cancer	0.00277	0.00311	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Epirubicin—pancreatic cancer	0.00276	0.0031	CcSEcCtD
Etidronic acid—Constipation—Erlotinib—pancreatic cancer	0.00275	0.00309	CcSEcCtD
Etidronic acid—Oesophagitis—Epirubicin—pancreatic cancer	0.00274	0.00308	CcSEcCtD
Etidronic acid—Erythema—Gemcitabine—pancreatic cancer	0.00274	0.00308	CcSEcCtD
Etidronic acid—Alopecia—Fluorouracil—pancreatic cancer	0.00273	0.00307	CcSEcCtD
Etidronic acid—Rash maculo-papular—Epirubicin—pancreatic cancer	0.00273	0.00306	CcSEcCtD
Etidronic acid—Muscle spasms—Irinotecan—pancreatic cancer	0.0027	0.00304	CcSEcCtD
Etidronic acid—Erythema—Fluorouracil—pancreatic cancer	0.00269	0.00303	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00266	0.00299	CcSEcCtD
Etidronic acid—Pancytopenia—Docetaxel—pancreatic cancer	0.00265	0.00298	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00263	0.00296	CcSEcCtD
Etidronic acid—Anaemia—Irinotecan—pancreatic cancer	0.0026	0.00292	CcSEcCtD
Etidronic acid—Urticaria—Tamoxifen—pancreatic cancer	0.00258	0.00291	CcSEcCtD
Etidronic acid—Abdominal pain—Tamoxifen—pancreatic cancer	0.00257	0.00289	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Doxorubicin—pancreatic cancer	0.00255	0.00287	CcSEcCtD
Etidronic acid—Abdominal pain—Erlotinib—pancreatic cancer	0.00254	0.00286	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00254	0.00285	CcSEcCtD
Etidronic acid—Oesophagitis—Doxorubicin—pancreatic cancer	0.00254	0.00285	CcSEcCtD
Etidronic acid—Anaemia—Gemcitabine—pancreatic cancer	0.00253	0.00285	CcSEcCtD
Etidronic acid—Rash maculo-papular—Doxorubicin—pancreatic cancer	0.00252	0.00284	CcSEcCtD
Etidronic acid—Leukopenia—Irinotecan—pancreatic cancer	0.00252	0.00283	CcSEcCtD
Etidronic acid—Paraesthesia—Sunitinib—pancreatic cancer	0.0025	0.00281	CcSEcCtD
Etidronic acid—Anaemia—Fluorouracil—pancreatic cancer	0.00249	0.0028	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00247	0.00277	CcSEcCtD
Etidronic acid—Dyspepsia—Sunitinib—pancreatic cancer	0.00245	0.00276	CcSEcCtD
Etidronic acid—Leukopenia—Gemcitabine—pancreatic cancer	0.00245	0.00276	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00244	0.00274	CcSEcCtD
Etidronic acid—Leukopenia—Fluorouracil—pancreatic cancer	0.00241	0.00271	CcSEcCtD
Etidronic acid—Hypersensitivity—Tamoxifen—pancreatic cancer	0.0024	0.00269	CcSEcCtD
Etidronic acid—Constipation—Sunitinib—pancreatic cancer	0.00238	0.00268	CcSEcCtD
Etidronic acid—Discomfort—Irinotecan—pancreatic cancer	0.00237	0.00266	CcSEcCtD
Etidronic acid—Arthralgia—Gemcitabine—pancreatic cancer	0.00233	0.00262	CcSEcCtD
Etidronic acid—Agranulocytosis—Docetaxel—pancreatic cancer	0.00232	0.00261	CcSEcCtD
Etidronic acid—Confusional state—Irinotecan—pancreatic cancer	0.00231	0.0026	CcSEcCtD
Etidronic acid—Discomfort—Gemcitabine—pancreatic cancer	0.0023	0.00259	CcSEcCtD
Etidronic acid—Pruritus—Tamoxifen—pancreatic cancer	0.0023	0.00259	CcSEcCtD
Etidronic acid—Infection—Irinotecan—pancreatic cancer	0.00228	0.00256	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00228	0.00256	CcSEcCtD
Etidronic acid—Pruritus—Erlotinib—pancreatic cancer	0.00228	0.00256	CcSEcCtD
Etidronic acid—Discomfort—Fluorouracil—pancreatic cancer	0.00227	0.00255	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—KDR—pancreatic cancer	0.00223	0.0228	CbGpPWpGaD
Etidronic acid—Diarrhoea—Tamoxifen—pancreatic cancer	0.00223	0.0025	CcSEcCtD
Etidronic acid—Infection—Gemcitabine—pancreatic cancer	0.00222	0.0025	CcSEcCtD
Etidronic acid—Confusional state—Fluorouracil—pancreatic cancer	0.00222	0.00249	CcSEcCtD
Etidronic acid—Abdominal pain—Sunitinib—pancreatic cancer	0.0022	0.00248	CcSEcCtD
Etidronic acid—Diarrhoea—Erlotinib—pancreatic cancer	0.0022	0.00248	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—TSC2—pancreatic cancer	0.0022	0.0225	CbGpPWpGaD
Etidronic acid—Infection—Fluorouracil—pancreatic cancer	0.00218	0.00245	CcSEcCtD
Etidronic acid—Osteoarthritis—Epirubicin—pancreatic cancer	0.00218	0.00245	CcSEcCtD
Etidronic acid—Erythema multiforme—Docetaxel—pancreatic cancer	0.00211	0.00237	CcSEcCtD
Etidronic acid—Vomiting—Tamoxifen—pancreatic cancer	0.00207	0.00233	CcSEcCtD
Etidronic acid—Paraesthesia—Irinotecan—pancreatic cancer	0.00206	0.00232	CcSEcCtD
Etidronic acid—Hypersensitivity—Sunitinib—pancreatic cancer	0.00205	0.00231	CcSEcCtD
Etidronic acid—Rash—Tamoxifen—pancreatic cancer	0.00205	0.00231	CcSEcCtD
Etidronic acid—Dermatitis—Tamoxifen—pancreatic cancer	0.00205	0.0023	CcSEcCtD
Etidronic acid—Vomiting—Erlotinib—pancreatic cancer	0.00205	0.0023	CcSEcCtD
Etidronic acid—Headache—Tamoxifen—pancreatic cancer	0.00204	0.00229	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00204	0.00229	CcSEcCtD
Etidronic acid—Rash—Erlotinib—pancreatic cancer	0.00203	0.00228	CcSEcCtD
Etidronic acid—Dermatitis—Erlotinib—pancreatic cancer	0.00203	0.00228	CcSEcCtD
Etidronic acid—Dyspepsia—Irinotecan—pancreatic cancer	0.00202	0.00227	CcSEcCtD
Etidronic acid—Headache—Erlotinib—pancreatic cancer	0.00202	0.00227	CcSEcCtD
Etidronic acid—Osteoarthritis—Doxorubicin—pancreatic cancer	0.00201	0.00226	CcSEcCtD
Etidronic acid—Paraesthesia—Gemcitabine—pancreatic cancer	0.00201	0.00226	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.002	0.00225	CcSEcCtD
Etidronic acid—Paraesthesia—Fluorouracil—pancreatic cancer	0.00197	0.00222	CcSEcCtD
Etidronic acid—Alopecia—Docetaxel—pancreatic cancer	0.00197	0.00222	CcSEcCtD
Etidronic acid—Pruritus—Sunitinib—pancreatic cancer	0.00197	0.00222	CcSEcCtD
Etidronic acid—Constipation—Irinotecan—pancreatic cancer	0.00196	0.00221	CcSEcCtD
Etidronic acid—Erythema—Docetaxel—pancreatic cancer	0.00194	0.00219	CcSEcCtD
Etidronic acid—Dyspepsia—Fluorouracil—pancreatic cancer	0.00194	0.00218	CcSEcCtD
Etidronic acid—Nausea—Tamoxifen—pancreatic cancer	0.00193	0.00217	CcSEcCtD
Etidronic acid—Gastritis—Epirubicin—pancreatic cancer	0.00193	0.00217	CcSEcCtD
Etidronic acid—Constipation—Gemcitabine—pancreatic cancer	0.00191	0.00215	CcSEcCtD
Etidronic acid—Nausea—Erlotinib—pancreatic cancer	0.00191	0.00215	CcSEcCtD
Etidronic acid—Diarrhoea—Sunitinib—pancreatic cancer	0.00191	0.00214	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—CDH1—pancreatic cancer	0.00189	0.0194	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Irinotecan—pancreatic cancer	0.00189	0.00213	CcSEcCtD
Etidronic acid—Asthma—Epirubicin—pancreatic cancer	0.00188	0.00212	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00188	0.00211	CcSEcCtD
Etidronic acid—Muscle spasms—Docetaxel—pancreatic cancer	0.00187	0.0021	CcSEcCtD
Etidronic acid—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00184	0.00207	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP2—pancreatic cancer	0.00182	0.0186	CbGpPWpGaD
Etidronic acid—Abdominal pain—Irinotecan—pancreatic cancer	0.00181	0.00204	CcSEcCtD
Etidronic acid—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00181	0.00204	CcSEcCtD
Etidronic acid—Anaemia—Docetaxel—pancreatic cancer	0.0018	0.00202	CcSEcCtD
Etidronic acid—Pancytopenia—Epirubicin—pancreatic cancer	0.00179	0.00201	CcSEcCtD
Etidronic acid—Gastritis—Doxorubicin—pancreatic cancer	0.00178	0.002	CcSEcCtD
Etidronic acid—Vomiting—Sunitinib—pancreatic cancer	0.00177	0.00199	CcSEcCtD
Etidronic acid—Rash—Sunitinib—pancreatic cancer	0.00176	0.00197	CcSEcCtD
Etidronic acid—Dermatitis—Sunitinib—pancreatic cancer	0.00176	0.00197	CcSEcCtD
Etidronic acid—Urticaria—Fluorouracil—pancreatic cancer	0.00175	0.00196	CcSEcCtD
Etidronic acid—Headache—Sunitinib—pancreatic cancer	0.00175	0.00196	CcSEcCtD
Etidronic acid—Asthma—Doxorubicin—pancreatic cancer	0.00174	0.00196	CcSEcCtD
Etidronic acid—Leukopenia—Docetaxel—pancreatic cancer	0.00174	0.00196	CcSEcCtD
Etidronic acid—Hypersensitivity—Irinotecan—pancreatic cancer	0.00169	0.0019	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00166	0.00187	CcSEcCtD
Etidronic acid—Arthralgia—Docetaxel—pancreatic cancer	0.00166	0.00186	CcSEcCtD
Etidronic acid—Nausea—Sunitinib—pancreatic cancer	0.00166	0.00186	CcSEcCtD
Etidronic acid—Pancytopenia—Doxorubicin—pancreatic cancer	0.00165	0.00186	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00164	0.00185	CcSEcCtD
Etidronic acid—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00162	0.00182	CcSEcCtD
Etidronic acid—Confusional state—Docetaxel—pancreatic cancer	0.0016	0.0018	CcSEcCtD
Etidronic acid—Pruritus—Gemcitabine—pancreatic cancer	0.00158	0.00178	CcSEcCtD
Etidronic acid—Infection—Docetaxel—pancreatic cancer	0.00158	0.00177	CcSEcCtD
Etidronic acid—Diarrhoea—Irinotecan—pancreatic cancer	0.00157	0.00177	CcSEcCtD
Etidronic acid—Agranulocytosis—Epirubicin—pancreatic cancer	0.00157	0.00176	CcSEcCtD
Etidronic acid—Pruritus—Fluorouracil—pancreatic cancer	0.00156	0.00175	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00154	0.00173	CcSEcCtD
Etidronic acid—Diarrhoea—Gemcitabine—pancreatic cancer	0.00153	0.00172	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00152	0.00171	CcSEcCtD
Etidronic acid—Diarrhoea—Fluorouracil—pancreatic cancer	0.0015	0.00169	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CB—pancreatic cancer	0.00149	0.0152	CbGpPWpGaD
Etidronic acid—Vomiting—Irinotecan—pancreatic cancer	0.00146	0.00164	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—CASP3—pancreatic cancer	0.00145	0.0148	CbGpPWpGaD
Etidronic acid—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00145	0.00163	CcSEcCtD
Etidronic acid—Rash—Irinotecan—pancreatic cancer	0.00145	0.00163	CcSEcCtD
Etidronic acid—Dermatitis—Irinotecan—pancreatic cancer	0.00145	0.00163	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00145	0.00162	CcSEcCtD
Etidronic acid—Headache—Irinotecan—pancreatic cancer	0.00144	0.00162	CcSEcCtD
Etidronic acid—Paraesthesia—Docetaxel—pancreatic cancer	0.00142	0.0016	CcSEcCtD
Etidronic acid—Erythema multiforme—Epirubicin—pancreatic cancer	0.00142	0.0016	CcSEcCtD
Etidronic acid—Vomiting—Gemcitabine—pancreatic cancer	0.00142	0.0016	CcSEcCtD
Etidronic acid—Rash—Gemcitabine—pancreatic cancer	0.00141	0.00158	CcSEcCtD
Etidronic acid—Dermatitis—Gemcitabine—pancreatic cancer	0.00141	0.00158	CcSEcCtD
Etidronic acid—Headache—Gemcitabine—pancreatic cancer	0.0014	0.00157	CcSEcCtD
Etidronic acid—Vomiting—Fluorouracil—pancreatic cancer	0.0014	0.00157	CcSEcCtD
Etidronic acid—Dyspepsia—Docetaxel—pancreatic cancer	0.0014	0.00157	CcSEcCtD
Etidronic acid—Rash—Fluorouracil—pancreatic cancer	0.00139	0.00156	CcSEcCtD
Etidronic acid—Dermatitis—Fluorouracil—pancreatic cancer	0.00138	0.00156	CcSEcCtD
Etidronic acid—Headache—Fluorouracil—pancreatic cancer	0.00138	0.00155	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP9—pancreatic cancer	0.00137	0.014	CbGpPWpGaD
Etidronic acid—Nausea—Irinotecan—pancreatic cancer	0.00136	0.00153	CcSEcCtD
Etidronic acid—Constipation—Docetaxel—pancreatic cancer	0.00136	0.00153	CcSEcCtD
Etidronic acid—Alopecia—Epirubicin—pancreatic cancer	0.00133	0.0015	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GDI1—pancreatic cancer	0.00133	0.0136	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GDI2—pancreatic cancer	0.00133	0.0136	CbGpPWpGaD
Etidronic acid—Nausea—Gemcitabine—pancreatic cancer	0.00133	0.00149	CcSEcCtD
Etidronic acid—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00132	0.00148	CcSEcCtD
Etidronic acid—Erythema—Epirubicin—pancreatic cancer	0.00131	0.00147	CcSEcCtD
Etidronic acid—Feeling abnormal—Docetaxel—pancreatic cancer	0.00131	0.00147	CcSEcCtD
Etidronic acid—Nausea—Fluorouracil—pancreatic cancer	0.00131	0.00147	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0013	0.00146	CcSEcCtD
Etidronic acid—Flatulence—Epirubicin—pancreatic cancer	0.00129	0.00145	CcSEcCtD
Etidronic acid—Muscle spasms—Epirubicin—pancreatic cancer	0.00126	0.00142	CcSEcCtD
Etidronic acid—Abdominal pain—Docetaxel—pancreatic cancer	0.00125	0.00141	CcSEcCtD
Etidronic acid—Alopecia—Doxorubicin—pancreatic cancer	0.00123	0.00138	CcSEcCtD
Etidronic acid—Erythema—Doxorubicin—pancreatic cancer	0.00121	0.00136	CcSEcCtD
Etidronic acid—Anaemia—Epirubicin—pancreatic cancer	0.00121	0.00136	CcSEcCtD
Etidronic acid—Flatulence—Doxorubicin—pancreatic cancer	0.0012	0.00134	CcSEcCtD
Etidronic acid—Leukopenia—Epirubicin—pancreatic cancer	0.00117	0.00132	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.00117	0.012	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Docetaxel—pancreatic cancer	0.00117	0.00131	CcSEcCtD
Etidronic acid—Muscle spasms—Doxorubicin—pancreatic cancer	0.00117	0.00131	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PRSS1—pancreatic cancer	0.00115	0.0118	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ZNRF3—pancreatic cancer	0.00115	0.0118	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—NRAS—pancreatic cancer	0.00115	0.0117	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—TGFB1—pancreatic cancer	0.00113	0.0115	CbGpPWpGaD
Etidronic acid—Pruritus—Docetaxel—pancreatic cancer	0.00112	0.00126	CcSEcCtD
Etidronic acid—Anaemia—Doxorubicin—pancreatic cancer	0.00112	0.00126	CcSEcCtD
Etidronic acid—Arthralgia—Epirubicin—pancreatic cancer	0.00112	0.00125	CcSEcCtD
Etidronic acid—Discomfort—Epirubicin—pancreatic cancer	0.0011	0.00124	CcSEcCtD
Etidronic acid—Leukopenia—Doxorubicin—pancreatic cancer	0.00109	0.00122	CcSEcCtD
Etidronic acid—Diarrhoea—Docetaxel—pancreatic cancer	0.00109	0.00122	CcSEcCtD
Etidronic acid—Confusional state—Epirubicin—pancreatic cancer	0.00108	0.00121	CcSEcCtD
Etidronic acid—Infection—Epirubicin—pancreatic cancer	0.00106	0.0012	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—DTX1—pancreatic cancer	0.00104	0.0106	CbGpPWpGaD
Etidronic acid—Arthralgia—Doxorubicin—pancreatic cancer	0.00103	0.00116	CcSEcCtD
Etidronic acid—Discomfort—Doxorubicin—pancreatic cancer	0.00102	0.00115	CcSEcCtD
Etidronic acid—Vomiting—Docetaxel—pancreatic cancer	0.00101	0.00113	CcSEcCtD
Etidronic acid—Rash—Docetaxel—pancreatic cancer	0.001	0.00112	CcSEcCtD
Etidronic acid—Dermatitis—Docetaxel—pancreatic cancer	0.000999	0.00112	CcSEcCtD
Etidronic acid—Confusional state—Doxorubicin—pancreatic cancer	0.000998	0.00112	CcSEcCtD
Etidronic acid—Headache—Docetaxel—pancreatic cancer	0.000994	0.00112	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KRAS—pancreatic cancer	0.000986	0.0101	CbGpPWpGaD
Etidronic acid—Infection—Doxorubicin—pancreatic cancer	0.000984	0.00111	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000975	0.0011	CcSEcCtD
Etidronic acid—Paraesthesia—Epirubicin—pancreatic cancer	0.000961	0.00108	CcSEcCtD
Etidronic acid—Nausea—Docetaxel—pancreatic cancer	0.000942	0.00106	CcSEcCtD
Etidronic acid—Dyspepsia—Epirubicin—pancreatic cancer	0.000942	0.00106	CcSEcCtD
Etidronic acid—Constipation—Epirubicin—pancreatic cancer	0.000915	0.00103	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CA—pancreatic cancer	0.000906	0.00927	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000902	0.00101	CcSEcCtD
Etidronic acid—Paraesthesia—Doxorubicin—pancreatic cancer	0.000889	0.000999	CcSEcCtD
Etidronic acid—Feeling abnormal—Epirubicin—pancreatic cancer	0.000882	0.000991	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000875	0.000984	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—DTX4—pancreatic cancer	0.000872	0.00891	CbGpPWpGaD
Etidronic acid—Dyspepsia—Doxorubicin—pancreatic cancer	0.000872	0.00098	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PRLHR—pancreatic cancer	0.000857	0.00876	CbGpPWpGaD
Etidronic acid—Urticaria—Epirubicin—pancreatic cancer	0.00085	0.000956	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PPP2R5B—pancreatic cancer	0.000848	0.00867	CbGpPWpGaD
Etidronic acid—Constipation—Doxorubicin—pancreatic cancer	0.000847	0.000952	CcSEcCtD
Etidronic acid—Abdominal pain—Epirubicin—pancreatic cancer	0.000846	0.000951	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—HRAS—pancreatic cancer	0.000839	0.00857	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HEY2—pancreatic cancer	0.000816	0.00835	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000816	0.000917	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00081	0.00091	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—ZNRF3—pancreatic cancer	0.000805	0.00823	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ACVR1B—pancreatic cancer	0.000805	0.00823	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Epirubicin—pancreatic cancer	0.000788	0.000886	CcSEcCtD
Etidronic acid—Urticaria—Doxorubicin—pancreatic cancer	0.000787	0.000884	CcSEcCtD
Etidronic acid—Abdominal pain—Doxorubicin—pancreatic cancer	0.000783	0.00088	CcSEcCtD
Etidronic acid—Pruritus—Epirubicin—pancreatic cancer	0.000757	0.000851	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HEY1—pancreatic cancer	0.000756	0.00773	CbGpPWpGaD
Etidronic acid—Diarrhoea—Epirubicin—pancreatic cancer	0.000732	0.000823	CcSEcCtD
Etidronic acid—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00073	0.00082	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—SSTR3—pancreatic cancer	0.000728	0.00745	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—DTX1—pancreatic cancer	0.000728	0.00745	CbGpPWpGaD
Etidronic acid—Pruritus—Doxorubicin—pancreatic cancer	0.000701	0.000787	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—SSTR1—pancreatic cancer	0.000698	0.00714	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PPY—pancreatic cancer	0.000685	0.007	CbGpPWpGaD
Etidronic acid—Vomiting—Epirubicin—pancreatic cancer	0.00068	0.000765	CcSEcCtD
Etidronic acid—Diarrhoea—Doxorubicin—pancreatic cancer	0.000678	0.000762	CcSEcCtD
Etidronic acid—Rash—Epirubicin—pancreatic cancer	0.000675	0.000758	CcSEcCtD
Etidronic acid—Dermatitis—Epirubicin—pancreatic cancer	0.000674	0.000758	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—SSTR2—pancreatic cancer	0.000672	0.00687	CbGpPWpGaD
Etidronic acid—Headache—Epirubicin—pancreatic cancer	0.00067	0.000754	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—JAG2—pancreatic cancer	0.00067	0.00685	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MEN1—pancreatic cancer	0.000661	0.00675	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SLC2A2—pancreatic cancer	0.000656	0.00671	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCKBR—pancreatic cancer	0.000649	0.00664	CbGpPWpGaD
Etidronic acid—Nausea—Epirubicin—pancreatic cancer	0.000636	0.000715	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—SHH—pancreatic cancer	0.00063	0.00644	CbGpPWpGaD
Etidronic acid—Vomiting—Doxorubicin—pancreatic cancer	0.00063	0.000708	CcSEcCtD
Etidronic acid—Rash—Doxorubicin—pancreatic cancer	0.000624	0.000702	CcSEcCtD
Etidronic acid—Dermatitis—Doxorubicin—pancreatic cancer	0.000624	0.000701	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—IAPP—pancreatic cancer	0.000622	0.00636	CbGpPWpGaD
Etidronic acid—Headache—Doxorubicin—pancreatic cancer	0.00062	0.000697	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GLI1—pancreatic cancer	0.00061	0.00624	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—DTX4—pancreatic cancer	0.00061	0.00624	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HSPA1B—pancreatic cancer	0.000597	0.00611	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000594	0.00607	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NRP1—pancreatic cancer	0.000594	0.00607	CbGpPWpGaD
Etidronic acid—Nausea—Doxorubicin—pancreatic cancer	0.000588	0.000661	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—HEY2—pancreatic cancer	0.000572	0.00584	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GAST—pancreatic cancer	0.000558	0.00571	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—JAG1—pancreatic cancer	0.000535	0.00547	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SCT—pancreatic cancer	0.000529	0.00541	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HEY1—pancreatic cancer	0.000529	0.00541	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD44—pancreatic cancer	0.000508	0.00519	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCK—pancreatic cancer	0.000505	0.00516	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HSPA1A—pancreatic cancer	0.000504	0.00516	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CNR2—pancreatic cancer	0.000492	0.00503	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000492	0.00503	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000484	0.00495	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JAG2—pancreatic cancer	0.000469	0.0048	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MEN1—pancreatic cancer	0.000463	0.00473	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SHH—pancreatic cancer	0.000441	0.00451	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000439	0.00448	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IAPP—pancreatic cancer	0.000436	0.00446	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000418	0.00428	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000418	0.00428	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SMAD4—pancreatic cancer	0.000401	0.0041	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HES1—pancreatic cancer	0.000392	0.004	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SST—pancreatic cancer	0.000383	0.00391	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JAG1—pancreatic cancer	0.000374	0.00383	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000373	0.00381	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CNR1—pancreatic cancer	0.000353	0.00361	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TERT—pancreatic cancer	0.000343	0.00351	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GCG—pancreatic cancer	0.000341	0.00349	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HIF1A—pancreatic cancer	0.000328	0.00335	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TSC2—pancreatic cancer	0.000327	0.00335	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000325	0.00333	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STK11—pancreatic cancer	0.000321	0.00328	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—APOE—pancreatic cancer	0.00032	0.00328	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NOTCH1—pancreatic cancer	0.000296	0.00302	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGF—pancreatic cancer	0.000286	0.00292	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000281	0.00287	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HES1—pancreatic cancer	0.000274	0.0028	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CD—pancreatic cancer	0.000254	0.0026	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TERT—pancreatic cancer	0.00024	0.00246	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HIF1A—pancreatic cancer	0.00023	0.00235	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TSC2—pancreatic cancer	0.000229	0.00234	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—APOE—pancreatic cancer	0.000224	0.00229	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CB—pancreatic cancer	0.000222	0.00226	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KDR—pancreatic cancer	0.00022	0.00225	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTGS2—pancreatic cancer	0.00022	0.00224	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000209	0.00214	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000207	0.00212	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000202	0.00207	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGF—pancreatic cancer	0.0002	0.00205	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CTNNB1—pancreatic cancer	0.000196	0.00201	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTEN—pancreatic cancer	0.000191	0.00196	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000178	0.00182	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SRC—pancreatic cancer	0.000178	0.00181	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT3—pancreatic cancer	0.000171	0.00175	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NRAS—pancreatic cancer	0.000171	0.00175	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—pancreatic cancer	0.000159	0.00163	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TGFB1—pancreatic cancer	0.000159	0.00162	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGFR—pancreatic cancer	0.000156	0.00159	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000155	0.00159	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL8—pancreatic cancer	0.000149	0.00152	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KRAS—pancreatic cancer	0.000147	0.0015	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CASP3—pancreatic cancer	0.000143	0.00146	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCND1—pancreatic cancer	0.000139	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000138	0.00141	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CA—pancreatic cancer	0.000135	0.00138	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MMP9—pancreatic cancer	0.000135	0.00138	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTEN—pancreatic cancer	0.000134	0.00137	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HRAS—pancreatic cancer	0.000125	0.00128	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SRC—pancreatic cancer	0.000124	0.00127	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFA—pancreatic cancer	0.000121	0.00124	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT3—pancreatic cancer	0.00012	0.00123	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NRAS—pancreatic cancer	0.00012	0.00122	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—pancreatic cancer	0.000111	0.00114	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFB1—pancreatic cancer	0.000111	0.00114	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT1—pancreatic cancer	0.00011	0.00113	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGFR—pancreatic cancer	0.000109	0.00111	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KRAS—pancreatic cancer	0.000103	0.00105	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CA—pancreatic cancer	9.46e-05	0.000967	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TP53—pancreatic cancer	9.15e-05	0.000935	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HRAS—pancreatic cancer	8.75e-05	0.000894	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT1—pancreatic cancer	7.73e-05	0.00079	CbGpPWpGaD
